Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
TOFA is a cell-permeable, potent, reversible, and competitive allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA). It inhibits the fatty acid biosynthesis by blocking the synthesis of malonyl-CoA. Uses: Hypolipidemic agents. Group: Pharmaceutical. CAS No. 54857-86-2. Pack Sizes: 100 mg. Product ID: B0084-374809. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). Group: Pharmaceutical. CAS No. 477600-75-2. Pack Sizes: 1 g. Product ID: B0084-453466. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Tofacitinib citrate
Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: http://en. wikipedia. org/wiki/Tofacitinib). Uses: Janus kinase inhibitors. Group: Pharmaceutical. CAS No. 540737-29-9. Pack Sizes: 500 mg. Product ID: NP2603. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Tofacitinib Citrate Impurities
Tofacitinib Citrate Impurities, central to quality control in the pharmaceutical sector, are critical in scrutinizing the developmental and stability aspects of Tofacitinib utilized for rheumatoid arthritis and ulcerative colitis treatment. Meticulous examination of these impurities fortifies drug safety and potency, thus ensuring compliance with rigorous regulatory mandates. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Tofacitinib Impurities
Tofacitinib Impurities constitute essential components in the quality assurance and safety evaluation of Tofacitinib, a Janus kinase inhibitor addressing diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. They facilitate researchers in guaranteeing drug purity, efficacy, and adherence to regulatory standards, ensuring rigorous pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Tofacitinib N-Oxide
Tofacitinib N-Oxide is an impurity of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Group: Pharmaceutical. CAS No. 2028267-73-2. Pack Sizes: 50 mg. Product ID: B2694-006572. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
(3R,4S)-Tofacitinib
(3R,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Group: Pharmaceutical. CAS No. 1092578-46-5. Pack Sizes: 2.5 mg. Product ID: B2694-463514. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
(3S,4R)-Tofacitinib
(3S,4R)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Group: Pharmaceutical. CAS No. 1092578-48-7. Pack Sizes: 2.5 mg. Product ID: B2694-463516. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
(3S,4S)-Tofacitinib
(3S,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Group: Pharmaceutical. CAS No. 1092578-47-6. Pack Sizes: 1 mg. Product ID: B2694-463515. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Butyl ester of TOFA
Butyl ester of TOFA. Industry Served: Inks
England
Dihydro Tofacitinib Citrate
An impurity of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Group: Pharmaceutical. Pack Sizes: 25 mg. Product ID: B2694-342495. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Pentaerythritol esters of TOFA
Pentaerythritol esters of TOFA
England
SULFO TOFA 10
TOFA 10. Group: Blended. CAS No. 61790-12-3. Pack Sizes: KEGS, DRUMS AND IBC'S.
SULFO SURFACTANTS
SULFO TOFA 2 + BHT
TOFA 2 + BHT. Group: Blended. CAS No. 61790-12-3. Pack Sizes: KEGS, DRUMS , IBC'S AND BULK.
SULFO SURFACTANTS
SULFO TOFA 5
TOFA 5. Group: Blended. CAS No. 61790-12-3. Pack Sizes: KEGS, DRUMS AND IBC'S.
An impurity of Tofacitinib, a Janus kinase inhibitor that could be used against rheumatoid arthritis. Group: Pharmaceutical. CAS No. 1640971-87-4. Pack Sizes: 5 mg. Product ID: B2694-063174. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Group: Pharmaceutical. CAS No. 1062580-52-2. Pack Sizes: 100 g. Product ID: B2694-150044. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
(3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
(3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Group: Pharmaceutical. CAS No. 1638499-31-6. Pack Sizes: 50 mg. Product ID: B2694-080065. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
(3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine
(3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Group: Pharmaceutical. CAS No. 1638499-33-8. Pack Sizes: 25 mg. Product ID: B2694-111800. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Group: Pharmaceutical. CAS No. 1354486-07-9. Pack Sizes: 5 g. Product ID: B2694-088366. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Upadacitinib
Upadacitinib is a selective JAK inhibitor under the development of AbbVie.ABT-494 is nearly 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. Preliminary evidence suggests that ABT-494 may spare Jak2 and Jak3 dependent signaling compared to tofacitinib. Phase II for the treatment of Atopic dermatitis and Crohn's disease, Phase III for the treatment of Rheumatoid arthritis and Ulcerative colitis was on-going. Uses: Rheumatoid arthritis; ulcerative colitis;atopic dermatitis; crohn's disease. Group: Pharmaceutical. CAS No. 1310726-60-3. Pack Sizes: 5 mg. Product ID: B0084-475295. Molecular formula: Custom synthesis is available. Send your inquiries for more information.
London
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.